Regulation of estrogen receptor alpha gene mediated by promoter B responsible for its enhanced expressionin human breast cancer.

We have previously reported that transcription from a distal promoter (promoter B) of the estrogen receptor alpha (ERalpha) gene is responsible for the increased expression of ERalpha in human breast carcinomas. This paper first characterized the promoter B region in terms of transient transfection experiments with luciferase using MCF-7 cells. Gradual deletions from the 5'-end of promoter B resulted in a decrease in promoter activity corresponding to the deleted lengths; a deletion of 39 bp in a non-coding exon 1a, drastically diminished the activity, indicating existence of an important cis -element. Furthermore, electrophoretic mobility shift assay and subsequent mutational analysis indicated that this element containing nucleotide sequence CTGGAAAG forms a specific DNA-protein complex. This element was capable of transactivating a heterogeneous SV40 promoter in MCF-7 cells, confirming that the element is a transcriptional enhancer; the trans -acting factor binding to the element was named ERBF-1 (estrogen receptor promoter B associated factor-1). The ERBF-1 was exclusively expressed in those cells expressing ERalpha mRNA transcribed from promoter B. Our findings indicate that ERBF-1 plays an important role in the expression of the ERalpha gene transcribed from promoter B, which is selectively utilized in breast cancer.

[1]  B. Weber,et al.  The biology of breast cancer , 1994, Current opinion in oncology.

[2]  I. Treilleux,et al.  A transcriptional enhancer required for the differential expression of the human estrogen receptor in breast cancers , 1997, Molecular and cellular biology.

[3]  P. Argos,et al.  Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A , 1986, Nature.

[4]  W. McGuire,et al.  Review: Steroid Receptors, Cellular Kinetics, and Lymph Node Status as Prognostic Factors in Breast Cancer , 1988 .

[5]  Gene regulation by steroid hormones , 1989, Cell.

[6]  J. Boyle,et al.  Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. , 1993, Genomics.

[7]  K. Grandien,et al.  The 5' flank of the rat estrogen receptor gene: structural characterization and evidence for tissue- and species-specific promoter utilization. , 1996, Journal of molecular endocrinology.

[8]  J. Gosden,et al.  Localization of the human oestrogen receptor gene to chromosome 6q24----q27 by in situ hybridization. , 1986, Cytogenetics and cell genetics.

[9]  J. Polman,et al.  ERβ: Identification and characterization of a novel human estrogen receptor , 1996 .

[10]  N. Copeland,et al.  Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. , 1997, Molecular endocrinology.

[11]  A. Nordheim,et al.  Gene regulation by Ets proteins. , 1993, Biochimica et biophysica acta.

[12]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[13]  R. Weigel,et al.  Quantitative analysis of the transcriptional start sites of estrogen receptor in breast carcinoma. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[14]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[15]  R. Weigel,et al.  Transcriptional regulation of estrogen receptor in breast carcinomas , 1995, Molecular and cellular biology.

[16]  M. Groudine,et al.  Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation. , 1995, Genes & development.

[17]  R. Sutherland,et al.  Expression of the PEA3 group of ETS‐related transcription factors in human breast‐cancer cells , 1997, International journal of cancer.

[18]  Wen-Lin Kuo,et al.  ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis , 1997, Oncogene.

[19]  T. Kurihara,et al.  Two promoters in expression of estrogen receptor messenger RNA in human breast cancer. , 1997, Carcinogenesis.

[20]  O. Gotoh,et al.  Interindividual difference in expression of human Ah receptor and related P450 genes. , 1994, Carcinogenesis.

[21]  Y. Makino,et al.  Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. , 1997, Nucleic acids research.

[22]  P. Cagle,et al.  Estrogen and progesterone receptors in bronchogenic carcinoma. , 1990, Cancer research.

[23]  J. Gustafsson,et al.  Localization of DNase I hypersensitive sites in the human oestrogen receptor gene correlates with the transcriptional activity of two differentially used promoters. , 1993, Journal of molecular endocrinology.

[24]  R. Weigel,et al.  Identification of ERF-1 as a member of the AP2 transcription factor family. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  O. Gotoh,et al.  Molecular cloning of the human AH receptor gene promoter. , 1994, Biochemical and biophysical research communications.

[26]  K. Chew,et al.  HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer , 1997, Oncogene.

[27]  J. Gustafsson,et al.  Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumor cell lines. , 1995, Endocrinology.

[28]  L. Ercolani,et al.  Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. , 1988, The Journal of biological chemistry.

[29]  R. Gambari,et al.  Sequencing of an RNA transcript of the human estrogen receptor gene: Evidence for a new transcriptional event , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[30]  F. Gannon,et al.  Evidence for a previously unidentified upstream exon in the human oestrogen receptor gene. , 1991, Journal of molecular endocrinology.

[31]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  P. Neiman,et al.  An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes , 1996, Molecular and cellular biology.